These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2281982)

  • 1. [The morphological characteristics of hepatocyte dysplasia].
    Dzhanaliev BR; Zolotarevskiĭ VB; Popova IV; Rodionov KV
    Arkh Patol; 1990; 52(8):17-22. PubMed ID: 2281982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The morphological characteristics of hepatocyte dysplasia].
    Serov VV; Beketova TP
    Arkh Patol; 1990; 52(1):36-42. PubMed ID: 2337391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular dysplasia: immunohistochemical and morphometrical evaluation.
    Pollice L; Ricco R; Russo S; Maiorano E; Pagniello G; Delfino-Pesce V
    Appl Pathol; 1988; 6(2):73-81. PubMed ID: 2455530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphological precursors of hepatocellular carcinoma: a morphometrical analysis.
    Giannini A; Zampi G; Bartoloni F; Omer S
    Hepatogastroenterology; 1987 Jun; 34(3):95-7. PubMed ID: 3038718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver cell dysplasia in liver cirrhosis and hepatocellular carcinoma.
    Szczepański W
    Pol J Pathol; 1997; 48(3):147-57. PubMed ID: 9401407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
    Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
    J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variant liver estrogen receptor transcripts already occur at an early stage of chronic liver disease.
    Villa E; Dugani A; Moles A; Camellini L; Grottola A; Buttafoco P; Merighi A; Ferretti I; Esposito P; Miglioli L; Bagni A; Troisi R; De Hemptinne B; Praet M; Callea F; Manenti F
    Hepatology; 1998 Apr; 27(4):983-8. PubMed ID: 9537437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large cell change (liver cell dysplasia) and hepatocellular carcinoma in cirrhosis: matched case-control study, pathological analysis, and pathogenetic hypothesis.
    Lee RG; Tsamandas AC; Demetris AJ
    Hepatology; 1997 Dec; 26(6):1415-22. PubMed ID: 9397980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can determination of the proliferative capacity of the nontumor portion predict the risk of tumor recurrence in the liver remnant after resection of human hepatocellular carcinoma?
    Chiu JH; Wu LH; Kao HL; Chang HM; Tsay SH; Loong CC; Chau GY; Lui WY
    Hepatology; 1993 Jul; 18(1):96-102. PubMed ID: 8392030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver cell dysplasia in alpha-1-antitrypsin deficiency.
    Cohen C; Derose PB
    Mod Pathol; 1994 Jan; 7(1):31-6. PubMed ID: 8159650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome after hepatitis B surface antigen seroclearance in patients with chronic hepatitis B.
    Arase Y; Ikeda K; Suzuki F; Suzuki Y; Saitoh S; Kobayashi M; Akuta N; Someya T; Hosaka T; Sezaki H; Kobayashi M; Kumada H
    Am J Med; 2006 Jan; 119(1):71.e9-16. PubMed ID: 16431195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of occult hepatitis B virus coinfection on the incidence of fibrosis and hepatocellular carcinoma in chronic hepatitis C.
    Matsuoka S; Nirei K; Tamura A; Nakamura H; Matsumura H; Oshiro S; Arakawa Y; Yamagami H; Tanaka N; Moriyama M
    Intervirology; 2008; 51(5):352-61. PubMed ID: 19127078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of ras and c-myc oncoproteins and hepatitis B surface antigen in human liver disease.
    Tiniakos D; Spandidos DA; Yiagnisis M; Tiniakos G
    Hepatogastroenterology; 1993 Feb; 40(1):37-40. PubMed ID: 8462926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of hepatocyte expression of hepatitis B viral antigens with histological activity and viral titer in chronic hepatitis B virus infection: an immunohistochemical study.
    Ramakrishna B; Mukhopadhya A; Kurian G
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1734-8. PubMed ID: 18713304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphometric assessment of nucleolar activity in liver cells during the evolutive pathway of chronic hepatitis C to cirrhosis.
    Betta PG; Robutti F; Fruttaldo L; Pavesi M; Pastormerlo M; Tallarida F
    Pathologica; 1993; 85(1095):31-6. PubMed ID: 8516024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver cell dysplasia and hepatocellular carcinoma in non-A, non-B hepatitis.
    Lefkowitch JH; Apfelbaum TF
    Arch Pathol Lab Med; 1987 Feb; 111(2):170-3. PubMed ID: 3028314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of alcohol on the liver in HBsAg carriers.
    Itoh S; Shimoji K
    Am J Gastroenterol; 1986 Sep; 81(9):779-82. PubMed ID: 3752040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic preneoplasia in hepatitis B virus transgenic mice.
    Toshkov I; Chisari FV; Bannasch P
    Hepatology; 1994 Nov; 20(5):1162-72. PubMed ID: 7927248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatitis delta virus infection: an immunohistochemical study].
    Preisegger KH; Denk H
    Wien Klin Wochenschr; 1989 Sep; 101(16):544-7. PubMed ID: 2678760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus surface and core antigens in the liver of primary hepatocellular carcinoma cases in Virginia.
    Swenson PD; Escobar MR; Silverman JF
    Acta Biol Acad Sci Hung; 1980; 31(1-3):321-8. PubMed ID: 6261496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.